Practical aspects of sharing controls between case-control studies

被引:12
作者
Bunin, GR
Baumgarten, M
Norman, SA
Strom, BL
Berlin, JA
机构
[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[5] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA
关键词
case-control study; efficiency; epidemiologic method; epidemiologic research design;
D O I
10.1002/pds.1130
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose We discuss the practical advantages and challenges of sharing controls among two or more concurrently conducted case-control studies. Methods We conducted two case-control studies, one of breast cancer and the other of endometrial cancer, with overlapping, shared control groups. The studies had overlapping geographic areas, identical telephone questionnaires and biosample collection, and identical age and race eligibility. Results Sharing controls reduced the number of potential controls that had to be identified by random-digit dialing by 25% and the number of eligible controls that had to be interviewed by 32%. The cost savings were approximately $296 000, or 7% of the program project that funded the studies. Conclusions The disadvantage of sharing controls was the complexity of the design and the additional investigator time required to plan, monitor, and adjust the design. In the situation presented here, the complexities would have been reduced greatly if we had not attempted to frequency match on age in both studies. Generally, sharing controls is likely to work well when strict frequency matching is not required and there is a large overlap of interview questions, other data to be collected, and eligibility criteria among the studies. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 13 条
[1]  
[Anonymous], 2000, CENS 2000
[2]   Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women [J].
Beresford, SAA ;
Weiss, NS ;
Voigt, LF ;
McKnight, B .
LANCET, 1997, 349 (9050) :458-461
[3]  
Carter JJ, 2001, CANCER RES, V61, P1934
[4]   Characteristics of women with and without breast augmentation [J].
Cook, LS ;
Daling, JR ;
Voigt, LF ;
deHart, P ;
Malone, KE ;
Stanford, JL ;
Weiss, NS ;
Brinton, LA ;
Gammon, MD ;
Brogan, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (20) :1612-1617
[5]   CIGARETTE-SMOKING AND THE RISK OF ANOGENITAL CANCER [J].
DALING, JR ;
SHERMAN, KJ ;
HISLOP, TG ;
MADEN, C ;
MANDELSON, MT ;
BECKMANN, AM ;
WEISS, NS .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (02) :180-189
[6]   RISK OF BREAST-CANCER AMONG YOUNG-WOMEN - RELATIONSHIP TO INDUCED-ABORTION [J].
DALING, JR ;
MALONE, KE ;
VOIGT, LF ;
WHITE, E ;
WEISS, NS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (21) :1584-1592
[7]   Characteristics of women who use perineal powders [J].
Rosenblatt, KA ;
Mathews, WA ;
Daling, JR ;
Voigt, LF ;
Malone, K .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (05) :753-756
[8]  
Rothman K. J., 1998, MODERN EPIDEMIOLOGY
[9]   COMBINED ESTROGEN AND PROGESTIN HORMONE REPLACEMENT THERAPY IN RELATION TO RISK OF BREAST-CANCER IN MIDDLE-AGED WOMEN [J].
STANFORD, JL ;
WEISS, NS ;
VOIGT, LF ;
DALING, JR ;
HABEL, LA ;
ROSSING, MA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (02) :137-142
[10]   PROGESTAGEN SUPPLEMENTATION OF EXOGENOUS ESTROGENS AND RISK OF ENDOMETRIAL CANCER [J].
VOIGT, LF ;
WEISS, NS ;
CHU, J ;
DALING, JR ;
MCKNIGHT, B ;
VANBELLE, G .
LANCET, 1991, 338 (8762) :274-277